news
Blood marker can predict heart disease risk in type-2 diabetes patients
Measuring a blood marker, copeptin, can successfully predict the risk of heart attacks in people with type-2 diabetes.
List view / Grid view
Diabetes
news
Exscientia to collaborate with Sanofi for EUR250mil multiple-product development
Exscientia has agreed a strategic research collaboration, and licence option agreement with Sanofi in the high-interest area of metabolic disease.
news
Pathways leading to beta cell division identified, may aid diabetes treatment
Pancreatic beta cells help maintain normal blood glucose levels by producing the hormone insulin -- the master regulator of energy (glucose). Impairment and the loss of beta cells interrupts insulin production, leading to type 1 and 2 diabetes.
news
Premature cell differentiation leads to disorders in pancreatic development
Neonatal diabetes mellitus (NDM), or diabetes among infants less than six months of age, is a rare form of diabetes caused by a mutation in genes crusial to the development or function of beta cells. In about half of such cases, the disease becomes permanent (PNDM). Mutations in more than…
news
3D visualisation of the pancreas – new tool in diabetes research
Umeå researchers have created datasets that map the three-dimensional distribution and volume of the insulin-producing cells in the pancreas.
news
Diabetic research suggests purslane herb extract mimics insulin
A new study has confirmed the anti-diabetic properties of the purslane herb extract Portulaca oleracea L.
news
New drug could prevent graft loss in pancreatic islet transplantation
5 December 2016 | By Niamh Louise Marriott, Digital Editor
In a rodent model of islet transplantation, ARA 290 markedly reduced transplantation-induced inflammation, resulting in a marked increase in islet survival...
news
Genetic differences in amino acid metabolism linked to high risk of diabetes
30 November 2016 | By Niamh Louise Marriott, Digital Content Producer
A study has identified the 5 genetic variants associated with higher levels of the branched-chain amino acids were associated with an increased risk...
article
How to be a research scientist: A conversation with Novo Nordisk’s Rahul Kapur
23 November 2016 | By Rahul Kapur, Head of Medical Affairs, Novo Nordisk UK and Ireland
We caught up with Novo Nordisk’s Rahul Kapur, to find out what it’s like to be at the forefront of diabetes research and what it takes to get there...
article
D is for Diabetes
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
D is for Diabetes - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest news and research into Diabetes...
news
3D printed customised insoles for diabetes patients
14 November 2016 | By Niamh Louise Marriott, Digital Content Producer
In the past, insoles for patients with diabetes were hand-made by orthopaedic shoemakers. In the future, these specialist shoemakers will be able to produce insoles more cost-effectively thanks to new software and the use of 3D printers. This approach means the mechanical properties of each insole can be assessed scientifically…
news
Diabetes opens floodgates to fructose
14 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The surprise is that diabetic mice absorb more fructose within minutes after it hits the stomach, sending it to the liver where it manufactures fat...
news
IDF calls for internationally standardised monitoring of cardiovascular disease in diabetics
29 September 2016 | By Niamh Louise Marriott, Digital Content Producer
It is difficult to estimate the global burden of cardiovascular disease in people with diabetes, due to lack of data and standardisation...
article
Vigilin: Could this drug target prevent a heart attack?
27 September 2016 | By ETH Zürich
Scientists identified a protein in liver cells, known as vigilin, which regulates the release of fats from the liver into the bloodstream. Find out more...
news
‘Library’ of de-prioritised pharma compounds available for researchers
UK scientists can apply for MRC funding to use any of the compounds in medical research studies to investigate the underlying mechanics of disease...
